Success Metrics

Clinical Success Rate
100.0%

Based on 5 completed trials

Completion Rate
100%(5/5)
Active Trials
1(14%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_1
2
29%
Ph phase_3
1
14%
Ph not_applicable
3
43%
Ph early_phase_1
1
14%

Phase Distribution

3

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution7 total trials
Early Phase 1First-in-human
1(14.3%)
Phase 1Safety & dosage
2(28.6%)
Phase 3Large-scale testing
1(14.3%)
N/ANon-phased studies
3(42.9%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

5 of 5 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

7

all time

Status Distribution
Active(1)
Completed(5)
Other(1)

Detailed Status

Completed5
Recruiting1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
7
Active
1
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Early Phase 11 (14.3%)
Phase 12 (28.6%)
Phase 31 (14.3%)
N/A3 (42.9%)

Trials by Status

completed571%
recruiting114%
unknown114%

Recent Activity

Clinical Trials (7)

Drug Details

Intervention Type
DIETARY SUPPLEMENT
Total Trials
7